Melatonin and cortisol circadian secretion during ethanol withdrawal in chronic alcoholics. 1994

S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
Dipartimento di Scienze Endocrinologiche e Metaboliche, Università di Genova, Italy.

Changes in central neurotransmission and in hypothalamo-pituitary function occur in both ethanol (ETOH) intake and withdrawal. Melatonin (MLT) secretion is regulated by the noradrenergic system, which is activated upon ETOH withdrawal. Experimental evidence exist that pineal gland may have a role in ETOH intake and preference in rats. Twenty-four hour urinary excretion of MLT was found to be increased during ETOH intake in chronic alcoholics. In this study we have determined 24h plasma levels of MLT and cortisol in 8 chronic alcoholic males hospitalized for a detoxication program and in 8 healthy controls. The study was performed just after admission, on the first day of ETOH withdrawal and after 14 days of controlled abstinence. Circadian periodicity has been evaluated by the cosinor method. The initial determinations corresponded to the acute withdrawal phase. Twenty-four hour plasma MLT mean levels on acute withdrawal were higher than after 14 days abstinence and than those found in controls. Large interindividual differences prevented the detection of statistical significance. The cosinor analysis disclosed the loss of circadian periodicity in the acute withdrawal. Significant 24h periodicity was restored after 14 days abstinence. Cortisol levels were significantly higher than those found on day 14 and in healthy controls. Twenty-four hour periodicity was maintained in both alcoholics series. A delay in cortisol acrophase occurred in acute withdrawal. The effects of Corticotropin Releasing Hormone infusion on cortisol secretion were significantly enhanced in the acute withdrawal phase in comparison with those occurring when patients were retested and with healthy controls.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
January 1984, Advances in biochemical psychopharmacology,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
September 1986, Drug and alcohol dependence,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
February 1992, Alcoholism, clinical and experimental research,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
February 1987, Journal of neurology, neurosurgery, and psychiatry,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
July 1987, Clinical chemistry,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
January 1988, Advances in alcohol & substance abuse,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
August 1996, Progress in neuro-psychopharmacology & biological psychiatry,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
January 1984, Alcohol and alcoholism (Oxford, Oxfordshire),
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
January 1982, Chronobiologia,
S Fonzi, and G P Solinas, and P Costelli, and C Parodi, and G Murialdo, and P Bo, and A Albergati, and L Montalbetti, and F Savoldi, and A Polleri
January 1982, Alcoholism, clinical and experimental research,
Copied contents to your clipboard!